Silver nanoparticles inhaled during pregnancy reach and affect the placenta and the foetus.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Fokkens, Paul Hb
Kreyling, Wolfgang G
Cassee, Flemming R
MetadataShow full item record
TitleSilver nanoparticles inhaled during pregnancy reach and affect the placenta and the foetus.
Published inNanotoxicology 2017; 11(5):687-98
PubliekssamenvattingRecently, interest for the potential impact of consumer-relevant engineered nanoparticles on pregnancy has dramatically increased. This study investigates whether inhaled silver nanoparticles (AgNPs) reach and cross mouse placental barrier and induce adverse effects. Apart from their relevance for the growing use in consumer products and biomedical applications, AgNPs are selected since they can be unequivocally identified in tissues. Pregnant mouse females are exposed during the first 15 days of gestation by nose-only inhalation to a freshly produced aerosol of 18-20 nm AgNPs for either 1 or 4 h, at a particle number concentration of 3.80 × 107 part./cm-3 and at a mass concentration of 640 μg/m³. AgNPs are identified and quantitated in maternal tissues, placentas and foetuses by transmission electron microscopy coupled with energy-dispersive X-ray spectroscopy and single-particle inductively coupled plasma mass spectrometry. Inhalation of AgNPs results in increased number of resorbed foetuses associated with reduced oestrogen plasma levels, in the 4 h/day exposed mothers. Increased expression of pregnancy-relevant inflammatory cytokines is also detected in the placentas of both groups. These results prove that NPs are able to reach and cross the mouse placenta and suggest that precaution should be taken with respect to acute exposure to nanoparticles during pregnancy.
- Particle size dependent deposition and pulmonary inflammation after short-term inhalation of silver nanoparticles.
- Authors: Braakhuis HM, Gosens I, Krystek P, Boere JA, Cassee FR, Fokkens PH, Post JA, van Loveren H, Park MV
- Issue date: 2014 Sep 17
- Induction of 8-hydroxydeoxyguanosine and ultrastructure alterations by silver nanoparticles attributing to placental transfer in pregnant rats and fetuses.
- Authors: Salim EI, Abdel-Halim KY, Abu-Risha SE, Abdel-Latif AS
- Issue date: 2019 Jun
- Distribution and accumulation of 10 nm silver nanoparticles in maternal tissues and visceral yolk sac of pregnant mice, and a potential effect on embryo growth.
- Authors: Austin CA, Hinkley GK, Mishra AR, Zhang Q, Umbreit TH, Betz MW, E Wildt B, Casey BJ, Francke-Carroll S, Hussain SM, Roberts SM, Brown KM, Goering PL
- Issue date: 2016 Aug
- Silver nanoparticles cause complications in pregnant mice.
- Authors: Zhang XF, Park JH, Choi YJ, Kang MH, Gurunathan S, Kim JH
- Issue date: 2015
- Lobar evenness of deposition/retention in rat lungs of inhaled silver nanoparticles: an approach for reducing animal use while maximizing endpoints.
- Authors: Park JD, Kim JK, Jo MS, Kim YH, Jeon KS, Lee JH, Faustman EM, Lee HK, Ahn K, Gulumian M, Oberdörster G, Yu IJ
- Issue date: 2019 Jan 7